China-based mobile health app developer Anxin Doctor has raised RMB200m ($28m) in a series B round featuring IDG Capital, a venture capital affiliate of media and data firm International Data Group, China Money Network reported on Wednesday.

Venture capital firms Matrix Partners China and Qiming Venture Partners also contributed to the round, which followed an eight-figure renminbi investment by VC firm Vision Plus Capital in 2015.

Established in 2015, Anxin Doctor operates a mobile app that enables patients to connect with…